Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada to Fund Genomics, Personalized Health Grants

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genome Canada is making plans to launch a new large-scale program focused on genomics and medicine that will provide between C$40 million (US$39 million) and C$65 million for projects lasting up to four years.

According to Genome Alberta, the Genomics and Personalized Health program is expected to launch either by the end of this year or in the beginning of 2012, but final details about the program are not yet available.

The program will fund research projects that focus on using genomics-based health studies that will help contribute to an evidence-based and more cost-effective health system, according to Genome Alberta's website.

Researchers receiving the funding will be expected to acquire matching funds from another supporter, and Genome Canada will provide up to 50 percent of proposed budgets of up to $5 million.

The University of Toronto also has posted some information on its website about the Genomics and Personalized Health program, noting that it will include funding for three programs at the Ontario Genomics Institute. These include a program to fund high-impact, high-risk and early stage technology development, a precommercialization and business development fund to help researchers move innovations toward the market, and a genomics capacity building workshop program.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.